D
David Bergqvist
Researcher at Uppsala University Hospital
Publications - 597
Citations - 23453
David Bergqvist is an academic researcher from Uppsala University Hospital. The author has contributed to research in topics: Thrombosis & Low molecular weight heparin. The author has an hindex of 71, co-authored 597 publications receiving 22200 citations. Previous affiliations of David Bergqvist include Lund University & Swedish Institute.
Papers
More filters
Journal ArticleDOI
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients.
Sam Schulman,U. Angerås,David Bergqvist,Bengt I. Eriksson,Michael R. Lassen,William D. Fisher +5 more
TL;DR: A definition of major bleeding that should be applicable to all agents that interfere with hemostasis is developed and is to seek approval from the regulatory authorities to enhance its incorporation into future clinical trial protocols.
Journal ArticleDOI
A prospective study of the incidence of deep‐vein thrombosis within a defined urban population
TL;DR: In a prospective study all positive phlebographies within the well‐defined population of the city of MalmÖ, Sweden, during 1987 were studied in order to determine the incidence of deep venous thrombosis (DVT), and risk factors were found to be in accordance with earlier studies.
Journal ArticleDOI
Low-Molecular-Weight Heparin (Enoxaparin) as Prophylaxis against Venous Thromboembolism after Total Hip Replacement
David Bergqvist,Göran Benoni,Ola Björgell,Hans Fredin,Urban Hedlundh,Sylvain Nicolas,Paul Nilsson,Göran Nylander +7 more
TL;DR: There were significantly fewer venous thromboembolic complications in patients undergoing elective hip replacement when prophylaxis with enoxaparin was given for a total of one month, rather than only during the hospitalization.
Journal ArticleDOI
Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment.
Lars Brattström,Bo Israelsson,Bo Norrving,David Bergqvist,Johan Thörne,Björn Hultberg,Arne Hamfelt +6 more
TL;DR: Data show that a substantial proportion of patients with early-onset vascular disease have impaired homocysteine metabolism, which may contribute to vascular disease, and that the impaired metabolism can be improved easily and without side effects.
Journal ArticleDOI
Classification and grading of chronic venous disease in the lower limbs. A consensus statement
Hugh G. Beebe,John J. Bergan,David Bergqvist,Bo Eklof,I. Eriksson,Mitchel P. Goldman,Lazar J. Greenfield,Robert W. Hobson,Claude Juhan,Robert L. Kistner,Nicos Labropoulos,G. Mark Malouf,J. O. Menzoian,Gregory L. Moneta,Kenneth A. Myers,Peter Neglén,Andrew N. Nicolaides,Thomas F. O'Donnell,H. Partsch,Michel Perrin,John M. Porter,Seshadri Raju,Norman M. Rich,Graeme D. Richardson,Harry Schanzer,Philip Coleridge Smith,D.Eugene Strandness,David S. Sumner +27 more
TL;DR: In this article, the classification and grading of chronic venous disease in the lower limbs of the human body was discussed. And a consensus statement was made on the diagnosis and classification of the disease.